$FSI
FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi

$fsi Overview Financials Valuation SEC Filings Company Website

2021 Form 10-K Financial Statement

#000149315222008027 Filed on March 29, 2022

Income Statement

Concept	2021	2020 Q4	2020
Revenue	$34.42M	$7.155M	$31.41M
YoY Change	9.58%	49.24%	14.46%
Cost Of Revenue	$23.02M	$5.275M	$21.64M
YoY Change	6.37%	51.53%	14.99%
Gross Profit	$11.40M	$1.880M	$9.766M
YoY Change	16.69%	43.15%	13.29%
Gross Profit Margin	33.11%	26.28%	31.1%
Selling, General & Admin	$5.572M	$1.542M	$5.314M
YoY Change	4.86%	10.22%	-11.05%
% of Gross Profit	48.89%	82.02%	54.41%
Research & Development	$116.4K		$81.42K
YoY Change	42.97%		-34.16%
% of Gross Profit	1.02%		0.83%
Depreciation & Amortization	$773.5K	$406.1K	$659.2K
YoY Change	17.33%	157.32%	54.09%
% of Gross Profit	6.79%	21.6%	6.75%
Operating Expenses	$5.913M	$1.566M	$5.649M
YoY Change	4.68%	7.88%	-15.85%
Operating Profit	$5.483M	$313.9K	$4.118M
YoY Change	33.17%	-326.64%	115.84%
Interest Expense	$360.1K	$140.6K	$260.7K
YoY Change	38.16%	-256.69%	-39.15%
% of Operating Profit	6.57%	44.8%	6.33%
Other Income/Expense, Net
YoY Change
Pretax Income	$6.651M	$587.9K	$5.191M
YoY Change	28.12%	-360.2%	124.27%
Income Tax	$2.356M	$542.6K	$1.607M
% Of Pretax Income	35.43%	92.29%	30.97%
Net Earnings	$3.449M	-$2.860K	$2.977M
YoY Change	15.86%	-100.55%	55.67%
Net Earnings / Revenue	10.02%	-0.04%	9.48%
Basic Earnings Per Share	$0.28
Diluted Earnings Per Share	$275.8K	-$233.60	$242.0K
COMMON SHARES
Basic Shares Outstanding	12.32M shares	12.24M shares	12.24M shares
Diluted Shares Outstanding	12.51M shares		12.30M shares

Balance Sheet

Concept	2021	2020 Q4	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.710M	$3.473M	$3.473M
YoY Change	64.43%	-4.45%	-4.45%
Cash & Equivalents	$5.710M	$3.473M	$3.473M
Short-Term Investments
Other Short-Term Assets	$1.468M	$1.302M	$1.302M
YoY Change	12.67%	495.71%	495.71%
Inventory	$9.502M	$8.372M	$8.372M
Prepaid Expenses		$302.4K
Receivables	$7.129M	$5.890M	$5.890M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$23.81M	$19.04M	$19.04M
YoY Change	25.06%	8.75%	8.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.149M	$5.142M	$5.625M
YoY Change	-8.47%	28.37%	17.32%
Goodwill		$2.534M
YoY Change		0.0%
Intangibles		$2.776M
YoY Change		-5.96%
Long-Term Investments	$5.433M	$4.776M	$4.785M
YoY Change	13.54%	149.33%	145.85%
Other Assets	$12.70K	$299.6K	$299.6K
YoY Change	-95.76%	-88.48%	-88.48%
Total Long-Term Assets	$15.74M	$16.05M	$16.05M
YoY Change	-1.92%	7.9%	7.9%
TOTAL ASSETS
Total Short-Term Assets	$23.81M	$19.04M	$19.04M
Total Long-Term Assets	$15.74M	$16.05M	$16.05M
Total Assets	$39.55M	$35.09M	$35.09M
YoY Change	12.72%	8.36%	8.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.283M	$558.1K	$558.1K
YoY Change	129.97%	-12.28%	-12.28%
Accrued Expenses	$534.8K	$1.226M	$1.514M
YoY Change	-64.67%	576.37%	157.91%
Deferred Revenue
YoY Change
Short-Term Debt	$2.301M	$2.116M	$2.116M
YoY Change	8.73%	-11.46%	-11.46%
Long-Term Debt Due	$793.6K	$848.8K	$848.8K
YoY Change	-6.51%	-29.07%	-29.07%
Total Short-Term Liabilities	$9.823M	$7.891M	$7.891M
YoY Change	24.48%	16.16%	16.16%
LONG-TERM LIABILITIES
Long-Term Debt	$1.573M	$2.999M	$2.999M
YoY Change	-47.55%	-5.81%	-18.59%
Other Long-Term Liabilities	$139.6K	$195.2K	$195.2K
YoY Change	-28.51%	-49.1%	-49.1%
Total Long-Term Liabilities	$1.713M	$2.999M	$3.194M
YoY Change	-46.38%	-5.81%	-21.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.823M	$7.891M	$7.891M
Total Long-Term Liabilities	$1.713M	$2.999M	$3.194M
Total Liabilities	$14.45M	$11.32M	$13.88M
YoY Change	4.09%	-5.03%	-4.07%
SHAREHOLDERS EQUITY
Retained Earnings		$5.433M
YoY Change		121.21%
Common Stock		$12.26K
YoY Change		0.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$25.10M	$21.21M	$21.21M
YoY Change
Total Liabilities & Shareholders Equity	$39.55M	$35.09M	$35.09M
YoY Change	12.72%	8.36%	8.36%

Cashflow Statement

Concept	2021	2020 Q4	2020
OPERATING ACTIVITIES
Net Income	$3.449M	-$2.860K	$2.977M
YoY Change	15.86%	-100.55%	55.67%
Depreciation, Depletion And Amortization	$773.5K	$406.1K	$659.2K
YoY Change	17.33%	157.32%	54.09%
Cash From Operating Activities	$4.536M	$151.1K	$5.705M
YoY Change	-20.5%	-109.04%	140.74%
INVESTING ACTIVITIES
Capital Expenditures	$782.2K	-$244.6K	$1.081M
YoY Change	-27.61%	-43.66%	-40.99%
Acquisitions			-$13.42K
YoY Change
Other Investing Activities	$122.7K	-$1.646M	-$2.144M
YoY Change	-105.72%	-601.27%	156.7%
Cash From Investing Activities	-$659.5K	-$1.890M	-$3.215M
YoY Change	-79.49%	1686.95%	20.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$140.4K		$39.75K
YoY Change	253.31%		-89.06%
Debt Paid & Issued, Net	$943.1K		$4.396M
YoY Change	-78.55%		310.32%
Cash From Financing Activities	-$1.710M	-49.12K	-$2.697M
YoY Change	-36.61%	-93.36%	-12.65%
NET CHANGE
Cash From Operating Activities	$4.536M	151.1K	$5.705M
Cash From Investing Activities	-$659.5K	-1.890M	-$3.215M
Cash From Financing Activities	-$1.710M	-49.12K	-$2.697M
Net Change In Cash	$2.263M	-1.788M	-$161.9K
YoY Change	-1497.7%	-28.94%	-94.98%
FREE CASH FLOW
Cash From Operating Activities	$4.536M	$151.1K	$5.705M
Capital Expenditures	$782.2K	-$244.6K	$1.081M
Free Cash Flow	$3.754M	$395.7K	$4.625M
YoY Change	-18.84%	-131.97%	758.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2020	FSI	Gain Loss On Sale Of Land GainLossOnSaleOfLand		usd
CY2020	FSI	Ppp Loan Forgiveness PppLoanForgiveness		usd
CY2021	FSI	Gain On Acquisition GainOnAcquisition		usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2020	FSI	Paycheck Protection Program Loan Forgiveness PaycheckProtectionProgramLoanForgiveness		usd
CY2021	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits		usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001069394
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A0
CY2021	us-gaap	Proceeds From Loans ProceedsFromLoans		usd
CY2021	FSI	Proceeds From Loan Acquired With Acquisition ProceedsFromLoanAcquiredWithAcquisition		usd
CY2020	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		usd
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-31540
CY2021	dei	Entity Registrant Name EntityRegistrantName	FLEXIBLE SOLUTIONS INTERNATIONAL, INC.
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	71-1630889
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	6001 54 Ave.
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Taber
CY2021	dei	Entity Address Country EntityAddressCountry	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	T1G 1X4
CY2021	dei	City Area Code CityAreaCode	(403)
CY2021	dei	Local Phone Number LocalPhoneNumber	223-2995
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2021	dei	Trading Symbol TradingSymbol	FSI
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	30491533	usd
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12375746	shares
CY2021	dei	Auditor Name AuditorName	Smythe LLP
CY2021	dei	Auditor Firm AuditorFirmId	995
CY2021	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2021Q4	us-gaap	Cash Cash	5710227	usd
CY2020Q4	us-gaap	Cash Cash	3472776	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1025347	usd
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7129329	usd
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5889813	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	9502005	usd
CY2020Q4	us-gaap	Inventory Net InventoryNet	8372476	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	442161	usd
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	302447	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	23809069	usd
CY2020Q4	us-gaap	Assets Current AssetsCurrent	19037512	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4931713	usd
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5142041	usd
CY2021Q4	FSI	Finite Lived Patent Gross FiniteLivedPatentGross	13699	usd
CY2020Q4	FSI	Finite Lived Patent Gross FiniteLivedPatentGross	30137	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	217267	usd
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	483113	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2600000	usd
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2776000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8540	usd
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8540	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5424010	usd
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	4776167	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2020Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12697	usd
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	299603	usd
CY2021Q4	us-gaap	Assets Assets	39551270	usd
CY2020Q4	us-gaap	Assets Assets	35087388	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1283486	usd
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	558105	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	457062	usd
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1225804	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	349004	usd
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	314277	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4561396	usd
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2540348	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2300819	usd
CY2020Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2116073	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	77715	usd
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	287900	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	793574	usd
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	848794	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9823056	usd
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7891301	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	139552	usd
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	195213	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	310162	usd
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	233751	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1573024	usd
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2998844	usd
CY2021Q4	us-gaap	Liabilities Liabilities	11845794	usd
CY2020Q4	us-gaap	Liabilities Liabilities	11319109	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12355246	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12355246	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12260545	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12260545	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	12355	usd
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	12261	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	12355	usd
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	12261	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16983648	usd
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16633190	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-775730	usd
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-872121	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8882360	usd
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5433198	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	25102633	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	21206528	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	2602843	usd
CY2020Q4	us-gaap	Minority Interest MinorityInterest	2561751	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27705476	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23768279	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	39551270	usd
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35087388	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34416335	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31407454	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23019824	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21641035	usd
CY2021	us-gaap	Gross Profit GrossProfit	11396511	usd
CY2020	us-gaap	Gross Profit GrossProfit	9766419	usd
CY2021	us-gaap	Salaries And Wages SalariesAndWages	2321285	usd
CY2020	us-gaap	Salaries And Wages SalariesAndWages	2169825	usd
CY2021	us-gaap	Officers Compensation OfficersCompensation	883460	usd
CY2020	us-gaap	Officers Compensation OfficersCompensation	804272	usd
CY2021	us-gaap	General Insurance Expense GeneralInsuranceExpense	581187	usd
CY2020	us-gaap	General Insurance Expense GeneralInsuranceExpense	479218	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	382663	usd
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	453639	usd
CY2021	FSI	Consulting Consulting	320759	usd
CY2020	FSI	Consulting Consulting	277277	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	285424	usd
CY2020	us-gaap	Professional Fees ProfessionalFees	283842	usd
CY2021	us-gaap	Other General Expense OtherGeneralExpense	269459	usd
CY2020	us-gaap	Other General Expense OtherGeneralExpense	250330	usd
CY2021	FSI	Interest Expenses InterestExpenses	199930	usd
CY2020	FSI	Interest Expenses InterestExpenses	260657	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	172185	usd
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	197196	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	116411	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	81422	usd
CY2021	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	107894	usd
CY2020	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	95053	usd
CY2021	FSI	Investor Relations And Transfer Agent Fee InvestorRelationsAndTransferAgentFee	94256	usd
CY2020	FSI	Investor Relations And Transfer Agent Fee InvestorRelationsAndTransferAgentFee	78930	usd
CY2021	FSI	Commissions Commissions	62632	usd
CY2020	FSI	Commissions Commissions	148922	usd
CY2021	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	45482	usd
CY2020	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	43535	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-25091	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6890	usd
CY2021	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	21523	usd
CY2020	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	17651	usd
CY2021	FSI	Shipping Cost ShippingCost	16567	usd
CY2020	FSI	Shipping Cost ShippingCost	12839	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6979	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1016	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	5913187	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	5648734	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	5483324	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	4117685	usd
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9490	usd
CY2021	FSI	Gain Loss On Sale Of Land GainLossOnSaleOfLand	44330	usd
CY2021	FSI	Ppp Loan Forgiveness PppLoanForgiveness	537960	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	507143	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	877358	usd
CY2020	FSI	Gain On Acquisition GainOnAcquisition	133341	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	77999	usd
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	53101	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6650756	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5190975	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	363317	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	409553	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1993182	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1197888	usd
CY2021	us-gaap	Profit Loss ProfitLoss	4294257	usd
CY2020	us-gaap	Profit Loss ProfitLoss	3583534	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	845095	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	606484	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3449162	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2977050	usd
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.28
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.24
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12316254	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12240641	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12505522	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12302552	shares
CY2021	us-gaap	Profit Loss ProfitLoss	4294257	usd
CY2020	us-gaap	Profit Loss ProfitLoss	3583534	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	96391	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	122489	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	4390648	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3706023	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	845095	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	606484	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3545553	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3099539	usd
CY2021	us-gaap	Profit Loss ProfitLoss	4294257	usd
CY2020	us-gaap	Profit Loss ProfitLoss	3583534	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	210112	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	156012	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	965935	usd
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	851672	usd
CY2021	FSI	Lease Right Of Use Financing LeaseRightOfUseFinancing	22057	usd
CY2020	FSI	Lease Right Of Use Financing LeaseRightOfUseFinancing	53768	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	265846	usd
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	331773	usd
CY2021	FSI	Gain Loss On Investment GainLossOnInvestment	507143	usd
CY2020	FSI	Gain Loss On Investment GainLossOnInvestment	877358	usd
CY2021	FSI	Bad Debt Expense BadDebtExpense	-6979	usd
CY2020	FSI	Bad Debt Expense BadDebtExpense	-1016	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	363317	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	409553	usd
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9490	usd
CY2021	FSI	Gain Loss On Sale Of Land GainLossOnSaleOfLand	44330	usd
CY2021	FSI	Paycheck Protection Program Loan Forgiveness PaycheckProtectionProgramLoanForgiveness	537960	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1246495	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1420614	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1275746	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1284607	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	139714	usd
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	83809	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	102856	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	553478	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2021048	usd
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	770243	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	34727	usd
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	101056	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4535746	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5705441	usd
CY2020	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits	22090	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	500000	usd
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	3152025	usd
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	359300	usd
CY2020	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	972295	usd
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-13419	usd
CY2021	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	263380	usd
CY2020	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	9490	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	782219	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1080598	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-659539	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3215329	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	184746	usd
CY2020	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-273909	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	943080	usd
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4395915	usd
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3413160	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	287903	usd
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	385541	usd
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	500000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	804003	usd
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	594882	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	140440	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	39750	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1709800	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2697337	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	96391	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45331	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2262798	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-161894	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4472776	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4634670	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6735574	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4472776	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5710227	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3472776	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	1025347	usd
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	1000000	usd
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	331773	usd
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	483113	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	464026	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	179029	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	260657	usd
CY2021	FSI	Inventory Additions In Accounts Payable And Accrued Liabilities InventoryAdditionsInAccountsPayableAndAccruedLiabilities	250923	usd
CY2020	FSI	Inventory Additions In Accounts Payable And Accrued Liabilities InventoryAdditionsInAccountsPayableAndAccruedLiabilities	397140	usd
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20461376	usd
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	122489	usd
CY2020	us-gaap	Profit Loss ProfitLoss	3583534	usd
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	39750	usd
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	594882	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	156012	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23768279	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	96391	usd
CY2021	us-gaap	Profit Loss ProfitLoss	4294257	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	140440	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	804003	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	210112	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27705476	usd
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zMbsb2EoCDn4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <i><span id="xdx_864_zsve7NV2tYL5">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and would impact the results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates and underlying assumptions are reviewed at each period end. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant areas requiring the use of management estimates include assumptions and estimates relating to the valuation of goodwill and intangible assets, asset impairment analysis, share-based payments, valuation allowances for deferred income tax assets, determination of useful lives of property, equipment and leaseholds and intangible assets, recoverability of accounts receivable, recoverability of investments, discount rates for right of use assets and the valuation of inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.055	pure
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zI05byQ0hGPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) <i><span id="xdx_868_z1ZwYcJLZdke">Risk Management</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s credit risk is primarily attributable to its accounts receivable. The amounts presented in the accompanying consolidated balance sheets are net of allowances for doubtful accounts, estimated by the Company’s management based on prior experience and the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure is minimized by dealing with only credit worthy counterparties. Revenue for the Company’s three primary customers totaled $<span id="xdx_902_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_zOS4EpWjI00g" title="Revenue from Contract with Customer, Excluding Assessed Tax">16,917,947</span> (<span id="xdx_902_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zfsy62oWCZHb" title="[custom:ConcentrationRiskThresholdPercentage]">49</span>%) for the year ended December 31, 2021 (2020 - $<span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_zjszlIo1nerc" title="Revenue from Contract with Customer, Excluding Assessed Tax">14,713,127</span> or <span id="xdx_90E_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zuInXhPSLzB5" title="[custom:ConcentrationRiskThresholdPercentage]">47</span>%). Accounts receivable for the Company’s three primary customers totaled $<span id="xdx_905_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_z7SYKm5Nz7K" title="Accounts Receivable, after Allowance for Credit Loss">4,940,995</span> (<span id="xdx_909_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zMBGqPdzI448" title="[custom:ConcentrationRiskThresholdPercentage]">69</span>%) at December 31, 2021 (2020 - $<span id="xdx_902_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember_zz2ZhwbIOSQg" title="Accounts Receivable, after Allowance for Credit Loss">3,986,284</span> or <span id="xdx_90D_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zt2tPUAnV8O7" title="[custom:ConcentrationRiskThresholdPercentage]">68</span>%).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit risk on cash and cash equivalents is limited because the Company limits its exposure to credit loss by placing its cash and cash equivalents with major financial institutions. The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced any losses in such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to foreign exchange and interest rate risk to the extent that market value rate fluctuations materially differ from financial assets and liabilities, subject to fixed long-term rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to foreign exchange risks, the Company is closely monitoring the fluctuations in the foreign currency exchange rates and the impact on the value of cash and cash equivalents, accounts receivable, and accounts payable and accrued liabilities. The Company has not hedged its exposure to currency fluctuations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to interest rate risk to the extent that the fair value or future cash flows for financial liabilities will fluctuate as a result of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to interest rate risk, the Company is closely monitoring fluctuations in market interest risks and will refinance its long-term debt where possible to obtain more favourable rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021	us-gaap	Equity Method Investment Description Of Principal Activities EquityMethodInvestmentDescriptionOfPrincipalActivities	Significant influence is generally deemed to exist if the Company’s ownership interest in the voting stock of the investee ranges between 20% and 50%, although other factors, such as representation on the investee’s board of directors, are considered in determining whether the equity method of accounting is appropriate.
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	789205	usd
CY2020	FSI	Operating Lease Assets Addition OperatingLeaseAssetsAddition	260661	usd
CY2020	FSI	Operating Leases Assets Termination OperatingLeasesAssetsTermination	-234980	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	265846	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	217267	usd
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	789205	usd
CY2020	FSI	Operating Leases Liability Addition OperatingLeasesLiabilityAddition	260661	usd
CY2020	FSI	Operating Leases Liability Termination OperatingLeasesLiabilityTermination	-234980	usd
CY2020	FSI	Lease Interest Expense LeaseInterestExpense	53768	usd
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	385541	usd
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	483113	usd
CY2021	FSI	Lease Interest Expense LeaseInterestExpense	22057	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	287903	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	217267	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	77715	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	139552	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	217267	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	78240	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	77100	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	70440	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	71940	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	297720	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	80453	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	217267	usd
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	7403308	usd
CY2020Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	6161249	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	273979	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	271436	usd
CY2021Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	7129329	usd
CY2020Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	5889813	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3417829	usd
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3393794	usd
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	152595	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	6084176	usd
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	4826087	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	9502005	usd
CY2020Q4	us-gaap	Inventory Net InventoryNet	8372476	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12538418	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7606705	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4931713	usd
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11982741	usd
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6840700	usd
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5142041	usd
CY2021	us-gaap	Depreciation Depreciation	773497	usd
CY2020	us-gaap	Depreciation Depreciation	659233	usd
CY2021Q1	us-gaap	Area Of Land AreaOfLand	3.3	sqft
CY2021Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	208079	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	194380	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13699	usd
CY2020Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	208211	usd
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	178074	usd
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30137	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16438	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16438	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	13699	usd
CY2020Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	770000	usd
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	770000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8540	usd
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8540	usd
CY2021	FSI	Investment Eliminated Upon Consolidation InvestmentEliminatedUponConsolidation	63165	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	13419	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	630000	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	85000	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	15797	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt	450000	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	66116	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	196506	usd
CY2021	FSI	Gain On Acquisition Of Enp Realty GainOnAcquisitionOfEnpRealty	133341	usd
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	3847638	usd
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	4380393	usd
CY2020	us-gaap	Proceeds From Loans ProceedsFromLoans	3413160	usd
CY2020	FSI	Proceeds From Loan Acquired With Acquisition ProceedsFromLoanAcquiredWithAcquisition	450000	usd
CY2021	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	537960	usd
CY2021	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	943080	usd
CY2020	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	4395915	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2366598	usd
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	3847638	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2366598	usd
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	3847638	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	793574	usd
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	848794	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1573024	usd
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2998844	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1309503	usd
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	739113	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	592394	usd
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	334361	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	91285	usd
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	124414	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1993182	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1197888	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	250153	usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	158308	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	113164	usd
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	71616	usd
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	179629	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	363317	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	409553	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2356499	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1607441	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6650756	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5190975	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3050	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3050	pure
CY2021	FSI	Expected Income Tax Recovery ExpectedIncomeTaxRecovery	2028481	usd
CY2020	FSI	Expected Income Tax Recovery ExpectedIncomeTaxRecovery	1583247	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-29508	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-60470	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-65027	usd
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	603422	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	337961	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-86696	usd
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-120372	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	171288	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-398386	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2356499	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1607441	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1993182	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1197888	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	363317	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	409553	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2356499	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1607441	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3449162	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2977050	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12316254	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12240641	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12505522	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12302552	shares
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.28
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.24
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	507000	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	1	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P5Y
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	635000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.35
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	172000	shares
CY2020	FSI	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Granted Options Exercise Price SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsExercisePrice	2.44
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.44
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	13000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.75
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	45000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.88
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	749000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.42
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	170000	shares
CY2021	FSI	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Granted Options Exercise Price SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsExercisePrice	3.61
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.61
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	34799	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.30
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	94701	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.58
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	789500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.78
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	564500	shares
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	2.63
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M12D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0123	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0037	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6328	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.7014	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.23
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.12
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34416335	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31407454	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	10296954	usd
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	10965566	usd

Files In Submission

Name	View Source	Status
0001493152-22-008027-index-headers.html	Edgar Link	pending
0001493152-22-008027-index.html	Edgar Link	pending
0001493152-22-008027.txt	Edgar Link	pending
0001493152-22-008027-xbrl.zip	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex23-1_002.jpg	Edgar Link	pending
ex23-1_003.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
fsi-20211231.xsd	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
fsi-20211231_def.xml	Edgar Link	unprocessable
fsi-20211231_lab.xml	Edgar Link	unprocessable
fsi-20211231_pre.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fsi-20211231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FSI
FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi

2021 Form 10-K Financial Statement

#000149315222008027 Filed on March 29, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FSI FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi

2021 Form 10-K Financial Statement

#000149315222008027 Filed on March 29, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FSI
FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi